CSIMarket Company Name, Ticker, Competitors, else..


Ikena Oncology Inc   (NASDAQ: IKNA)
Other Ticker:  
 

Ikena Oncology Inc

IKNA's Fundamental analysis



Ikena Oncology Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2827

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Ikena Oncology Inc net loss decreased from $-17 millions, to $-10 millions in III. Quarter 2024,

• More on IKNA's Growth


Ikena Oncology Inc
realized a net loss in trailing twelve months.

Ikena Oncology Inc realized cash reduction of $ -1.59 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 110.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.


• More on IKNA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 2.78

Ikena Oncology Inc
realized net loss in trailing twelve months.

Ikena Oncology Inc realized cash outflow of $ -1.59per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 110.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.59.

Ikena Oncology Inc Price to Book Ratio is at 0.54 lower than Industry Avg. of 383.35. and higher than S&P 500 Avg. of 0.01

• More on IKNA's Valuation

•  Market Capitalization (Millions $) 72
•  Shares Outstanding (Millions) 48
•  Employees 62
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -60
•  Cash Flow (TTM) (Millions $) -76
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 2.78

•  Market Capitalization (Millions $) 72
•  Shares Outstanding (Millions) 48
•  Employees 62
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -60
•  Cash Flow (TTM) (Millions $) -76
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 15.32
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.11
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com